Lab reportStandard
Tirzepatide
Tirzepatide 1
Tirzepatide 2

Reported purity99.688%

Task number#110143

Tested25 FEB 2026

VerificationReport available

View report
Product information

About Tirzepatide

Research product

Product overview

Tirzepatide is a dual GIP and GLP-1 pathway research peptide supplied by UWA Biotech for laboratory investigations involving metabolic signalling, incretin receptor activity, peptide pharmacology and advanced obesity and metabolic research applications.

Available formats

  • 10 × 5mg
  • 10 × 10mg
  • 10 × 15mg
  • 10 × 20mg
  • 10 × 30mg
  • 10 × 60mg
  • MOQ: 10 vials / 1 box

Verification

  • Purity: 99.688%
  • Tested: 25 FEB 2026
  • Task number: #110143
  • Unique key: 5IVMYW1E5G18

Research applications

  • GLP-1 pathway research
  • GIP receptor investigations
  • Metabolic signalling studies
  • Incretin peptide research
Research use only

This product is supplied exclusively for laboratory research use. Not for human consumption, therapeutic use or clinical application.

Purity99.688%

Format5mg

MOQ10 vials / 1 box

Ships fromUnited States

Product verification

Laboratory report

Report linked
Reported purity99.688%Analytical result shown in the supplied report.
Task number#110143
Tested25 FEB 2026
Report typeJanoshik / COA
Unique ID5IVMYW1E5G18
View report pageOpen original report
Verification documentLaboratory report preview
Full report
Tirzepatide verification report
Research use only

This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.

From$70.00
Buy now